Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gloucester Pharmaceuticals

Explore full profile

Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through approvals and commercialization

Cambridge, United StatesFounded 2002Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2009
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Gloucester Pharmaceuticals and the history behind them.

About Gloucester Pharmaceuticals

Gloucester Pharmacy is a healthcare provider that goes beyond the traditional pharmacy model by offering personalized care to its clients. Located in the Middle Peninsula, the pharmacy serves a diverse range of customers, including individuals seeking prescription refills and those in need of over-the-counter remedies. The business operates in the healthcare market, focusing on both prescription and non-prescription products. Its business model revolves around providing high-quality, personalized healthcare services, which include filling prescriptions and offering a complete line of non-prescription remedies. The pharmacy generates revenue through the sale of these products and services, aiming to meet the unique healthcare needs of its community.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2002
Headquarters
Cambridge, United States
Employees
4
Open positions
None listed
Dealroom signal
59.5/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Immune System, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Dec 2009 $640M $640M Celgene —
SERIES DOther financing Aug 2009 $29M $116M Novo Ventures · ProQuest Investments · Prospect Venture Partners · Apple Tree Partners —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Gloucester Pharmaceuticals website traffic

Latest recorded traffic for Gloucester Pharmaceuticals is 0 monthly website visits. Gloucester Pharmaceuticals's team declined 42.9% over the past year.

Latest monthly visits0 1-year team growth-42.9%
Monthly website visitsNov 2018–May 2020
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Amphista TherapeuticsNext-generation therapeutics for targeted protein degradation Great Abington, United Kingdom Operational 39 $82M $212M
HEPHAISTOS-PharmaDeveloping Tomorrow’s immuno-oncology and modulator therapy | A single platform for defeating cancer and much more Orsay, France Operational
Index PharmaceuticalsDeveloping drugs to treat inflammatory bowel disease that can help patients return to a normal life Solna kommun, Sweden Operational
Corvus PharmaceuticalsClinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer Burlingame, United States Operational
Biosortia PharmaceuticalsBiosortia is working on new drugs from deep access to the chemistry of the microbiome for immuno-oncology & immunological therapeutics Dublin, United States Operational
OncobiologicsPrivately-held biopharmaceutical company Cranbury Township, United States Operational
Gossamer BioFocused on the discovery and development of novel and differentiated therapeutic products San Diego, United States Operational
ProkariumOral vaccines for infectious diseases London, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • Novo Ventures
  • ProQuest Investments
  • Prospect Venture Partners
  • Apple Tree Partners
  • Rho Capital Partners

Other known investors1 additional known investor

  • Celgene

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gloucester Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gloucester Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.